Skip to main content
. 2018 May 19;25(1):1127–1136. doi: 10.1080/10717544.2018.1469688

Figure 3.

Figure 3.

Efficacy of inhaled versus IV topotecan for lung cancer therapy. The survival (A,B) and lung tumor burden (C,D) of rats with the fast-growing H1975 (A and C) and moderately growing A549 (B and D) derived lung cancer were compared between treatment groups.